United Advisor Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Buy
28,224
+677
+2% +$38.9K 0.17% 152
2026
Q1
$1.67M Buy
27,547
+554
+2% +$32.3K 0.21% 121
2025
Q4
$1.46M Buy
26,993
+7,373
+38% +$355K 0.18% 136
2025
Q3
$885K Buy
19,620
+6,479
+49% +$303K 0.12% 181
2025
Q2
$608K Buy
13,141
+35
+0.3% +$1.72K 0.11% 193
2025
Q1
$799K Sell
13,106
-7,285
-36% -$425K 0.16% 135
2024
Q4
$1.15M Sell
20,391
-1,003
-5% -$56K 0.23% 108
2024
Q3
$1.11M Buy
21,394
+11,307
+112% +$530K 0.25% 96
2024
Q2
$419K Buy
10,087
+188
+2% +$8.41K 0.13% 156
2024
Q1
$537K Buy
+9,899
New +$504K 0.2% 109

Other funds holding BMY

United Advisor Group's BMY Position: Q2 2026 in Review

United Advisor Group increased its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, buying an estimated $38.9K and bringing the position to 28,224 shares worth $1.63M. The position accounts for 0.17% of the portfolio, ranked #152.

United Advisor Group first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.67M in Q1 2026. 2,521 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • United Advisor Group held 28,224 shares of Bristol-Myers Squibb worth $1.63M as of Q2 2026.
  • United Advisor Group bought 677 Bristol-Myers Squibb shares in Q2 2026, an estimated $38.9K.
  • Bristol-Myers Squibb made up 0.17% of United Advisor Group's portfolio in Q2 2026, its #152 holding.
  • United Advisor Group first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
  • United Advisor Group's Bristol-Myers Squibb position peaked at $1.67M in Q1 2026.
  • 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on United Advisor Group's 13F filing for Q2 2026, filed 29 Jul 2026.